• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-羟基化和乙酰化对正常受试者中氨苯砜药代动力学的影响。

The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects.

作者信息

May D G, Porter J A, Uetrecht J P, Wilkinson G R, Branch R A

机构信息

Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.

出版信息

Clin Pharmacol Ther. 1990 Dec;48(6):619-27. doi: 10.1038/clpt.1990.204.

DOI:10.1038/clpt.1990.204
PMID:2249373
Abstract

The relative importance of N-hydroxylation and acetylation of dapsone to the oral clearance of dapsone (100 mg) was investigated in seven healthy volunteers. Plasma dapsone and monoacetyldapsone concentrations rose rapidly with subsequent similar monoexponential elimination. The oral clearance of dapsone was low (33 +/- 14 ml/min), with a threefold variability. Four subjects were identified as fast acetylators; however, differences in acetylation did not explain the variability in oral clearance. The cumulative urinary recoveries of dapsone and its hydroxylamine were approximately 20% of the dose. The formation clearance of hydroxylamine, which exhibited a tenfold intersubject variability, was closely associated with the oral clearance of dapsone (r = 0.96). Thus, the formation of the hydroxylamine is more important than acetylation in determining dapsone's intersubject variability in oral clearance. Variation in N-hydroxylation may have clinical consequences, because the hydroxylamine is considered to be important in dapsone-mediated toxicity.

摘要

在7名健康志愿者中研究了氨苯砜的N-羟基化和乙酰化对氨苯砜(100毫克)口服清除率的相对重要性。血浆氨苯砜和单乙酰氨苯砜浓度迅速上升,随后呈相似的单指数消除。氨苯砜的口服清除率较低(33±14毫升/分钟),具有三倍的变异性。4名受试者被确定为快速乙酰化者;然而,乙酰化的差异并不能解释口服清除率的变异性。氨苯砜及其羟胺的累积尿回收率约为给药剂量的20%。羟胺的生成清除率在受试者间表现出10倍的变异性,与氨苯砜的口服清除率密切相关(r = 0.96)。因此,在决定氨苯砜口服清除率的受试者间变异性方面,羟胺的生成比乙酰化更重要。N-羟基化的变化可能具有临床意义,因为羟胺被认为在氨苯砜介导的毒性中起重要作用。

相似文献

1
The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects.N-羟基化和乙酰化对正常受试者中氨苯砜药代动力学的影响。
Clin Pharmacol Ther. 1990 Dec;48(6):619-27. doi: 10.1038/clpt.1990.204.
2
Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.炎症性皮肤病患者中氨苯砜毒性的发生:氨苯砜乙酰化和羟化活性作为危险因素
Clin Pharmacol Ther. 1999 Jun;65(6):598-605. doi: 10.1016/S0009-9236(99)90081-4.
3
The disposition of dapsone in cirrhosis.氨苯砜在肝硬化患者中的处置情况。
Clin Pharmacol Ther. 1992 Jun;51(6):689-700. doi: 10.1038/clpt.1992.81.
4
Intra-adipose administration of monoacetyldapsone to healthy volunteers.对健康志愿者进行单乙酰氨苯砜的脂肪内给药。
Int J Lepr Other Mycobact Dis. 1986 Dec;54(4):510-6.
5
Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population.在白种人群体中,氨苯砜N-羟化酶(一种假定的细胞色素P4503A4活性探针)的频率分布。
Clin Pharmacol Ther. 1994 May;55(5):492-500. doi: 10.1038/clpt.1994.62.
6
Reassessment of dapsone as a marker of acetylator phenotypes.对氨苯砜作为乙酰化酶表型标志物的重新评估。
Int J Clin Pharmacol Ther Toxicol. 1991 Jul;29(7):262-8.
7
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo.在体外和体内,氨苯砜通过CYP2E1代谢为其羟胺。
Clin Pharmacol Ther. 1995 Nov;58(5):556-66. doi: 10.1016/0009-9236(95)90176-0.
8
Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.氯胍对健康志愿者中氨苯砜药代动力学无影响。
Chemotherapy. 1993 Jul-Aug;39(4):235-41. doi: 10.1159/000239131.
9
N-acetylation polymorphism of dapsone in a Japanese population.日本人群中氨苯砜的N-乙酰化多态性
Br J Clin Pharmacol. 1988 Apr;25(4):487-94. doi: 10.1111/j.1365-2125.1988.tb03333.x.
10
The effect of acetylation and deacetylation on the disposition of dapsone and monoacetyl dapsone hydroxylamines in human erythrocytes in-vitro.乙酰化和去乙酰化对氨苯砜及单乙酰氨苯砜羟胺在人红细胞体外处置的影响。
J Pharm Pharmacol. 1996 Apr;48(4):401-6. doi: 10.1111/j.2042-7158.1996.tb05941.x.

引用本文的文献

1
Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study.在健康的尼日利亚人中进行的氨苯砜非房室和群体药代动力学分析:一项初步研究。
Br J Clin Pharmacol. 2023 Nov;89(11):3454-3459. doi: 10.1111/bcp.15862. Epub 2023 Aug 15.
2
Dapsone-Associated Anemia in Heart Transplant Recipients with Normal Glucose-6-Phosphate Dehydrogenase Activity.葡萄糖-6-磷酸脱氢酶活性正常的心脏移植受者中与氨苯砜相关的贫血
J Clin Med. 2022 Oct 28;11(21):6378. doi: 10.3390/jcm11216378.
3
Case Study 10: A Case to Investigate Acetyl Transferase Kinetics.
案例研究 10:乙酰转移酶动力学研究案例
Methods Mol Biol. 2021;2342:781-808. doi: 10.1007/978-1-0716-1554-6_29.
4
Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.皮肤科药物的神经和神经精神不良反应
CNS Drugs. 2016 Dec;30(12):1149-1168. doi: 10.1007/s40263-016-0392-x.
5
How Clinically Relevant is Dapsone-related Peripheral Neuropathy?: An Overview of Available Data with Emphasis on Clinical Recognition.氨苯砜相关的周围神经病变在临床上的相关性如何?:现有数据概述,重点是临床识别。
J Clin Aesthet Dermatol. 2010 Mar;3(3):19-21.
6
Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding.对氨苯砜羟胺通过膜重排和抗体结合诱导人红细胞过早清除。
Br J Pharmacol. 2010 Nov;161(5):1186-99. doi: 10.1111/j.1476-5381.2010.00962.x.
7
Pharmacokinetic considerations in clinical toxicology: clinical applications.临床毒理学中的药代动力学考量:临床应用
Clin Pharmacokinet. 2007;46(11):897-939. doi: 10.2165/00003088-200746110-00001.
8
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.磺胺甲恶唑和氨苯砜在正常人皮肤成纤维细胞中的生物活化、蛋白质半抗原化及毒性
Toxicol Appl Pharmacol. 2006 Sep 1;215(2):158-67. doi: 10.1016/j.taap.2006.02.006. Epub 2006 Apr 17.
9
A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study.一种用于评估主要药物代谢酶的便捷五药鸡尾酒:一项初步研究。
Br J Clin Pharmacol. 2004 Sep;58(3):288-97. doi: 10.1111/j.1365-2125.2004.02162.x.
10
Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.鉴定代谢抗寄生虫药物的人细胞色素P450,并根据体外数据预测体内药物肝脏清除率。
Eur J Clin Pharmacol. 2003 Sep;59(5-6):429-42. doi: 10.1007/s00228-003-0636-9. Epub 2003 Aug 12.